EGFR and neoplasm: Some image biomarkers may now be informative for predicting MGMT promoter methylation status or prognosis of glioblastoma22,45,46, for prognosis for breast cancer47,48, and for predicting EGFR mutation status or prognosis of non-small cell lung cancer23,24.